Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 3/2013

01.03.2013 | Symposium: Papers Presented at the 2011 ISOLS Meeting in Beijing, China

Which Implant Is Best After Failed Treatment for Pathologic Femur Fractures?

verfasst von: Jonathan Agner Forsberg, MD, Rikard Wedin, MD, PhD, Henrik Bauer, MD, PhD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Successful treatment of pathologic femur fractures can preserve a patient’s independence and quality of life. The choice of implant depends on several disease- and patient-specific variables; however, its durability must generally match the patient’s estimated life expectancy. Failures do occur, however, it is unclear which implants are associated with greater risk of failure.

Questions/Purposes

We evaluated patients with femoral metastases in whom implants failed to determine (1) the rate of reoperation; (2) the timing of and most common causes for failure; and (3) incidence of perioperative complications and death.

Methods

From a prospectively collected registry, we identified 93 patients operated on for failed treatment of femoral metastases from 1990 to 2010. We excluded five patients who subsequently underwent amputations leaving 88 who underwent salvage procedures. These included intramedullary nails (n = 11), endoprostheses (n = 61), and plate fixation (n = 16). The primary outcome was reoperation after salvage treatment.

Results

Seventeen of the 88 patients (19%) required subsequent reoperation a median of 10 months (interquartile range, 4–14) from the time of salvage surgery: 15 for material failure, one for local progression of tumor, and one for a combination of these. Five patients died within 4 weeks of surgery. Although perioperative complications were higher in the endoprosthesis group and dislocations occurred, overall treatment failures after salvage surgery were lower in the that group (four of 61) compared the group with plate fixation (eight of 16) and intramedullary nail groups (five of 11).

Conclusions

Despite relatively common perioperative complications, salvage using endoprostheses may be associated with fewer treatment failures as compared with internal fixation.

Level of Evidence

Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
Literatur
2.
Zurück zum Zitat Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66:143–146.PubMedCrossRef Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66:143–146.PubMedCrossRef
3.
Zurück zum Zitat Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br. 2009;91:108–112.PubMed Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br. 2009;91:108–112.PubMed
4.
Zurück zum Zitat Clohisy DR, Le CT, Cheng EY, Dykes DC, Thompson RCJ. Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastases. J Orthop Res. 2000;18:1–9.PubMedCrossRef Clohisy DR, Le CT, Cheng EY, Dykes DC, Thompson RCJ. Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastases. J Orthop Res. 2000;18:1–9.PubMedCrossRef
5.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205.PubMedCrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205.PubMedCrossRef
6.
Zurück zum Zitat Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian belief network. PloS One. 2011;6:e19956.PubMedCrossRef Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian belief network. PloS One. 2011;6:e19956.PubMedCrossRef
7.
Zurück zum Zitat Harrington KD, Sim FH, Enis JE, Johnston JO, Diok HM, Gristina AG. Methylmethacrylate as an adjunct in internal fixation of pathological fractures. Experience with three hundred and seventy-five cases. J Bone Joint Surg Am. 1976;58:1047–1055.PubMed Harrington KD, Sim FH, Enis JE, Johnston JO, Diok HM, Gristina AG. Methylmethacrylate as an adjunct in internal fixation of pathological fractures. Experience with three hundred and seventy-five cases. J Bone Joint Surg Am. 1976;58:1047–1055.PubMed
8.
Zurück zum Zitat Jacofsky DJ, Haidukewych GJ, Zhang H, Sim FH. Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip. Clin Orthop Relat Res. 2004;427:52–56.PubMedCrossRef Jacofsky DJ, Haidukewych GJ, Zhang H, Sim FH. Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip. Clin Orthop Relat Res. 2004;427:52–56.PubMedCrossRef
9.
Zurück zum Zitat Lane JM, Sculco TP, Zolan S. Treatment of pathological fractures of the hip by endoprosthetic replacement. J Bone Joint Surg Am. 1980;62:954–959.PubMed Lane JM, Sculco TP, Zolan S. Treatment of pathological fractures of the hip by endoprosthetic replacement. J Bone Joint Surg Am. 1980;62:954–959.PubMed
10.
Zurück zum Zitat Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23:6072–6082.PubMedCrossRef Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23:6072–6082.PubMedCrossRef
11.
Zurück zum Zitat Nilsson J, Gustafson P. Surgery for metastatic lesions of the femur: good outcome after 245 operations in 216 patients. Injury. 2008;39:404–410.PubMedCrossRef Nilsson J, Gustafson P. Surgery for metastatic lesions of the femur: good outcome after 245 operations in 216 patients. Injury. 2008;39:404–410.PubMedCrossRef
12.
Zurück zum Zitat Potter BK, Chow VE, Adams SC, Letson GD, Temple HT. Endoprosthetic proximal femur replacement: metastatic versus primary tumors. Surg Oncol. 2009;18:343–349.PubMedCrossRef Potter BK, Chow VE, Adams SC, Letson GD, Temple HT. Endoprosthetic proximal femur replacement: metastatic versus primary tumors. Surg Oncol. 2009;18:343–349.PubMedCrossRef
13.
Zurück zum Zitat Sarahrudi K, Greitbauer M, Platzer P, Hausmann JT, Heinz T, Vecsei V. Surgical treatment of metastatic fractures of the femur: a retrospective analysis of 142 patients. J Trauma. 2009;66:1158–1163.PubMedCrossRef Sarahrudi K, Greitbauer M, Platzer P, Hausmann JT, Heinz T, Vecsei V. Surgical treatment of metastatic fractures of the femur: a retrospective analysis of 142 patients. J Trauma. 2009;66:1158–1163.PubMedCrossRef
14.
Zurück zum Zitat Schulman KL, Kohles J. Economic burden of metastatic bone disease in the US. Cancer. 2007;109:2334–2342.PubMedCrossRef Schulman KL, Kohles J. Economic burden of metastatic bone disease in the US. Cancer. 2007;109:2334–2342.PubMedCrossRef
15.
Zurück zum Zitat Springer BD, Fehring TK, Griffin WL, Odum SM, Masonis JL. Why revision total hip arthroplasty fails. Clin Orthop Relat Res. 2009;467:166–173.PubMedCrossRef Springer BD, Fehring TK, Griffin WL, Odum SM, Masonis JL. Why revision total hip arthroplasty fails. Clin Orthop Relat Res. 2009;467:166–173.PubMedCrossRef
16.
Zurück zum Zitat Steensma M, Boland PJ, Morris CD, Athanasian E, Healey JH. Endoprosthetic treatment is more durable for pathologic proximal femur fractures. Clin Orthop Relat Res. 2011;470:920–926.PubMedCrossRef Steensma M, Boland PJ, Morris CD, Athanasian E, Healey JH. Endoprosthetic treatment is more durable for pathologic proximal femur fractures. Clin Orthop Relat Res. 2011;470:920–926.PubMedCrossRef
17.
Zurück zum Zitat Ward WG, Holsenbeck S, Dorey FJ, Spang J, Howe D. Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res. 2003;415(Suppl):S230–244.PubMedCrossRef Ward WG, Holsenbeck S, Dorey FJ, Spang J, Howe D. Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res. 2003;415(Suppl):S230–244.PubMedCrossRef
18.
Zurück zum Zitat Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg Br. 2005;87:1653–1657.PubMed Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg Br. 2005;87:1653–1657.PubMed
19.
Zurück zum Zitat Wedin R, Bauer HC, Wersall P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop Relat Res. 1999;128–139. Wedin R, Bauer HC, Wersall P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop Relat Res. 1999;128–139.
20.
Zurück zum Zitat Wedin R, Hansen BH, Laitinen M, Trovik C, Zaikova O, Bergh P, Kalen A, Schwarz-Lausten G, von Steyern FV, Walloe A, Keller J, Weiss RJ. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg. 2012;21:1045–1055.CrossRef Wedin R, Hansen BH, Laitinen M, Trovik C, Zaikova O, Bergh P, Kalen A, Schwarz-Lausten G, von Steyern FV, Walloe A, Keller J, Weiss RJ. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg. 2012;21:1045–1055.CrossRef
Metadaten
Titel
Which Implant Is Best After Failed Treatment for Pathologic Femur Fractures?
verfasst von
Jonathan Agner Forsberg, MD
Rikard Wedin, MD, PhD
Henrik Bauer, MD, PhD
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 3/2013
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-012-2558-2

Weitere Artikel der Ausgabe 3/2013

Clinical Orthopaedics and Related Research® 3/2013 Zur Ausgabe

Symposium: Papers Presented at the 2011 ISOLS Meeting in Beijing, China

Making a Case for the Socioeconomic Determinacy of Survival in Osteosarcoma

Symposium: Highlights from the First Combined 2011 Meeting of the Musculoskeletal Tumor Society and Connective Tissue Oncology Society

Haptic Robot-assisted Surgery Improves Accuracy of Wide Resection of Bone Tumors: A Pilot Study

Symposium: Highlights from the First Combined 2011 Meeting of the Musculoskeletal Tumor Society and Connective Tissue Oncology Society

Treating Metastatic Disease: Which Survival Model Is Best Suited for the Clinic?

Symposium: Papers Presented at the 2011 ISOLS Meeting in Beijing, China

Computer-assisted Tumor Surgery in Malignant Bone Tumors

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.